A Study to Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) in Patients With Polycythemia Vera
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of IONIS-TMPRSS6-LRx in reducing
the frequency of phlebotomy and in improving quality of life assessments in participants with
polycythemia vera.